Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2008;112:297-303
© 2008 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chen, X.
Right arrow Articles by Scholl, T. O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X.
Right arrow Articles by Scholl, T. O.
Related Collections
Right arrow Nutrition/metabolism
Right arrow Preterm labor
Right arrow Epidemiology/public health

ORIGINAL RESEARCH

Association of Elevated Free Fatty Acids During Late Pregnancy With Preterm Delivery

Xinhua Chen, MD and Theresa O. Scholl, PhD, MPH

From the Department of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey–School of Osteopathic Medicine, Stratford, New Jersey.

OBJECTIVE: To examine the association between moderately elevated maternal plasma free fatty acids (FFAs) during late pregnancy and preterm delivery.

METHODS: In a prospective observational cohort with 523 healthy pregnant women, fasting plasma FFAs were measured during the third trimester. Socioeconomic, demographic, and anthropometric measures were collected at entry to prenatal care, and pregnancy outcomes were abstracted from medical record at delivery.

RESULTS: After control for confounders including prepregnant body mass index (multiple logistic regression analysis), women who had moderately elevated plasma FFAs (in the highest tertile), showed a greater than threefold increased risk of preterm delivery (adjusted odds ratio (AOR) 3.49, 95% (CI) 1.73–7.03, P<.001). The associations persisted in women who had spontaneous preterm delivery (AOR 2.35, 95% CI 1.05–5.28, P<.05) and after excluding women with gestational diabetes mellitus and preeclampsia (AOR 3.30, 95% CI 1.38–7.87, P<.01). Additional stratified analyses showed that the association of high maternal FFAs and increased risk of preterm delivery was independent of prepregnant obesity.

CONCLUSION: Elevated fasting plasma FFA levels at 30 weeks of gestation were associated with an increased risk of preterm delivery. This effect was independent of prepregnant obesity and several other known risk factors for preterm delivery, including cigarette smoking, ethnicity, and prior preterm delivery. These data may have important clinical significance because they provide a possible link between preterm delivery and high lipid levels, a known risk factor for cardiovascular disease.

LEVEL OF EVIDENCE: II







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Obstetricians and Gynecologists.